World immunisation week – 24-30 April
This annual event is championed by the World Health Organisation (WHO) and promotes the use of vaccines to protect people of all ages against preventable diseases, ranging from pre-school vaccinations like MMR, to flu and shingles which are available to older age groups. (Source: NHS Networks)
Source: NHS Networks - April 22, 2022 Category: UK Health Source Type: news

Shingles Risk Increased For People Over 50 Who Had COVID, Study Says
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p25").init({"mcp":"cbs","width":"100%","height":"100%","video":"6228464","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p25","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5","customMetadata":{"vi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 20, 2022 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News COVID-19 Covid-19 Boston, MA Health Healthwatch Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Shingles Source Type: news

Use of RZV in Immunocompromised Adults Aged > 19 Years Use of RZV in Immunocompromised Adults Aged > 19 Years
Recombinant zoster vaccine is the first herpes zoster vaccine approved for use in immunocompromised persons. Review its use in this population in this brief article.Morbidity & Mortality Weekly Report (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 11, 2022 Category: Transplant Surgery Tags: Public Health & Prevention Journal Article Source Type: news

Shingles Vaccination for Immunocompromised Adults Shingles Vaccination for Immunocompromised Adults
In January 2022, CDC updated recommendations for shingles vaccination to include people 19 years and older who are or will be immunocompromised.CDC Expert Commentary (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 22, 2022 Category: Transplant Surgery Tags: Infectious Diseases Commentary Source Type: news

Shingles: Symptom of the condition that could be an early sign
SHINGLES is a skin infection which can cause a number of uncomfortable symptoms but is easily treatable. Nevertheless, it can prove dangerous to certain vulnerable individuals. Now one of the teams behind one the COVID-19 vaccines is turning its aim on the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - February 25, 2022 Category: Consumer Health News Source Type: news

Shingrix vaccine with 90% effectiveness set to be offered to over-70s in the UK
The highly effective new vaccine Shingrix could cut the risk of infection by more than 90 per cent. In 2018, presenter Eamonn Holmes revealed he had shingles and was forced to take time off from ITV. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2022 Category: Consumer Health News Source Type: news

Herpes Zoster Vaccine Can Save Your Patients' Eyesight Herpes Zoster Vaccine Can Save Your Patients' Eyesight
Herpes zoster ophthalmicus can be devastating. Dr Rapuano urges all ophthalmologists to discuss the zoster vaccine with their patients.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2022 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Recommendations Updated for Recombinant Zoster Vaccine
THURSDAY, Jan. 20, 2022 -- Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and older; the recommendations are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2022 Category: Pharmaceuticals Source Type: news

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 20, 2022 Category: American Health Tags: Adult Health Adult Vaccinations Advisory Committee on Immunization Practices (ACIP) MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Source Type: news

Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring and painful disease that impacts about one in three people in the United States during their lifetime. (Source: World Pharma News)
Source: World Pharma News - January 6, 2022 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

Flu/Shingles Shot Combo May Hurt Future Flu Vaccine Uptake Flu/Shingles Shot Combo May Hurt Future Flu Vaccine Uptake
The year after people receive concurrent flu and shingles shots, flu shots dip, which could mean that people are incorrectly associating adverse effects with the flu vaccine, researchers suggest.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 22, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Some confuse symptoms of the shingles vaccine for flu shot if received on same day
Researchers from Harvard Medical School found that people who receive their shingles and flu vaccines together are less likely to return and get their flu shot again in subsequent years. (Source: the Mail online | Health)
Source: the Mail online | Health - November 19, 2021 Category: Consumer Health News Source Type: news

Janssen Reports Positive Topline Week 48 Phase 2 Results for TREMFYA ® (guselkumab) in Adults With Moderately to Severely Active Crohn's Disease
SPRING HOUSE, PENNSYLVANIA, November 17, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced topline results from the Phase 2 GALAXI 1 clinical trial which showed rates of clinical remission (Crohn’s Disease Activity Index [CDAI]<150) previously reported at week 12 increased at week 48 among adults with moderately to severely active Crohn’s disease (CD) treated with TREMFYA® (guselkumab).1 At week 48, 65 percent of patients receiving TREMFYA achieved clinical remission. TREMFYA is under investigation and not currently approved for the treatment of CD in the U.S.2Janssen previously...
Source: Johnson and Johnson - November 17, 2021 Category: Pharmaceuticals Source Type: news

Wonderjabs! How vaccines for shingles and flu could beat stroke and even dementia, too
Mounting evidence suggests certain jabs given every year in the UK may also reduce the risk of seemingly unrelated illnesses, from ear infections to strokes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 8, 2021 Category: Consumer Health News Source Type: news

Study: Shingrix shingles vaccine riskier for Guillain-Barr é than older shot
Older adults who receive the Shingrix shingles vaccines are more than twice as likely to develop Guillain-Barr é syndrome compared with those given the older Zostavax product, a JAMA Internal Medicine study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 1, 2021 Category: Consumer Health News Source Type: news